The use of early postoperative prostate-specific antigen to stratify risk in patients with positive surgical margins after radical prostatectomy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The use of early postoperative prostate-specific antigen to stratify risk in patients with positive surgical margins after radical prostatectomy

Published:2014-10-02 Issue:1 Volume:14 Page:
ISSN:1471-2490
Container-title:BMC Urology
language:en
Short-container-title:BMC Urol

Author:

Vesely Stepan,Jarolim Ladislav,Duskova Katerina,Schmidt Marek,Dusek Pavel,Babjuk Marko

Publisher

Springer Science and Business Media LLC

Subject

Urology,Reproductive Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/1471-2490-14-79.pdf

Reference25 articles.

1. Ohori M, Wheeler TM, Kattan MW, Goto Y, Scardino PT: Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol. 1995, 154: 1818-1824. 10.1016/S0022-5347(01)66792-2.

2. Fontenot PA, Mansour AM: Reporting positive surgical margins after radical prostatectomy: time for standardization. BJU Int. 2013, 111: 290-299. 10.1111/j.1464-410X.2012.11640.x.

3. Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, Henning JM, Stier DM, Carroll PR: Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CAPSURE database. J Urol. 2000, 163: 1171-1177. 10.1016/S0022-5347(05)67716-6.

4. Raldow A, Hamstra DA, Kim SN, Yu JB: Adjuvant radiotherapy after radical prostatectomy: Evidence and analysis. Cancer Treat Rev. 2011, 37: 89-96. 10.1016/j.ctrv.2010.07.001.

5. Bolla M, van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Colombel M, van de Beek C, Verhagen P, van den Bergh A, Sternberg C, Gasser T, van Tienhoven G, Scalliet P, Haustermans K, Collette L: Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomized controlled trial (EORTC trial 22911). Lancet. 2012, 380: 2018-2027. 10.1016/S0140-6736(12)61253-7.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-Specific Antigen as an Ultrasensitive Biomarker for Patients with Early Recurrent Prostate Cancer: How Low Shall We Go? A Systematic Review;Biomedicines;2024-04-08

2. Long-Term Oncological Outcomes for Histologically Confirmed High-Risk Prostate Cancer;Journal of Nippon Medical School;2023-04-25

3. Establishment and Validation of a Novel Prediction Model for Early Natural Biochemical Recurrence After Radical Prostatectomy Based on Post-Operative PSA at Sixth Week;Cancer Management and Research;2023-04

4. Clinicopathological and oncological significance of persistent prostate-specific antigen after radical prostatectomy: A systematic review and meta-analysis;Asian Journal of Urology;2022-05

5. Prognostic Significance of Prostate-Specific Antigen Persistence after Radical Prostatectomy: A Systematic Review and Meta-Analysis;Cancers;2021-02-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3